Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anebulo Pharmaceuticals Inc (ANEB)

Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anebulo Pharmaceuticals Inc 1017 Ranch Road 620 South SUITE 107 LAKEWAY TX 78734 USA

www.anebulo.com Employees: 3 P: 512-598-0931

Description:

Anebulo Pharmaceuticals Inc. is a clinical-stage biotechnology company. It involved in developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The company's product candidate includes ANEB-001. Anebulo Pharmaceuticals Inc. is based in Texas, United States.

Key Statistics

Overview:

Market Capitalization, $K 39,418
Enterprise Value, $K 36,328
Shares Outstanding, K 25,933
Annual Sales, $ 0 K
Annual Net Income, $ -8,200 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,200 K
EBIT, $ -8,170 K
EBITDA, $ -8,020 K
60-Month Beta -1.00
% of Insider Shareholders 85.90%
% of Institutional Shareholders 28.40%
Float, K 3,657
% Float 14.10%
Short Volume Ratio 0.02

Growth:

1-Year Return -29.77%
3-Year Return -75.76%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 11/13/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -0.30
EPS Growth vs. Prev Qtr -60.00%
EPS Growth vs. Prev Year 20.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ANEB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -184.40%
Return-on-Assets % -158.14%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 20.76
Book Value/Share 0.07
Interest Coverage -53.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar